- US FDA approves Pfizer's nasal spray for migraine.
- The drug, Zavzpret, was approved for the treatment of acute migraine.
- Zavzpret is expected to launch in July and is comparable in price to other FDA-approved migraine medicines.
US FDA approves Pfizer's nasal spray for migraine
The U.S. Food and Drug Administration on Friday approved Pfizer Inc's nasal spray for migraine, giving patients access to a potentially fast-acting pain-relief option for headaches.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/PTZLI6A6NZPDXDPADM2FPCZ6EA.jpg)